Authors
Latest Article
Gloomy Number Forecast
Robert Giugliano, MD, is a senior investigator with the TIMI Study Group, staff physician in the Cardiovascular Division at Brigham and Women’s Hospital, and associate professor of medicine at Harvard Medical School. Dr. Giugliano’s areas of research interest include novel antithrombotic, fibrinolytic agents, and lipid-lowering therapies, and patient outcomes following Acute Coronary Syndromes. He has authored more than 200 articles and chapters, and delivered hundreds of lectures. Dr. Giugliano is the principal investigator for the ENGAGE-AF TIMI 48 trial, and a member of the Operations Committees and lead TIMI investigator for the IMPROVE-IT, FOURIER, and EARLY ACS trials.
Advertisement
Advertisement
Trending on HCPLive
1
Oral STAT6 Degrader KT-621 Reduces EASI by 62.6% in Atopic Dermatitis
2
Q&A: Tulisokibart Results and TL1A Inhibition in HS, With Alexa Kimball, MD, MPH
3
Q&A: Asthma Remission from Year 1 To Year 2 With Depemokimab
4
Risankizumab Shows Higher 3-Year Drug Survival in Psoriasis With PsA
5

